Merit Medical Systems Stock News

Emerald Advisers LLC lifted its stake in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 21.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 449,787 shares of the medical instruments suppliers stock after purchasing an additional 80,586 shares during the period. Merit Medical []

Calamos Advisors LLC purchased a new position in Merit Medical Systems, Inc. (NASDAQ:MMSI) during the 3rd quarter, Holdings Channel reports. The institutional investor purchased 47,532 shares of the medical instruments suppliers stock, valued at approximately $3,413,000. Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. []

Key Companies Covered in the Global Surgical Blades & Scalpels Market Research Report Are FEATHER Safety Razor Co., Ltd., KAI Group, Aspen Surgical, B. Braun Melsungen AG, Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Hu-Friedy Mfg. Co., LLC, SteriLance Medical (Suzhou) Inc., Merit Medical Systems, Inc., Shanghai Medical Corporation, Swann-Morton Limited, and other key market players. Key Companies Covered in the Global Surgical Blades & Scalpels Market Research Report Are FEATHER Safety Razor Co., Ltd., KAI Group, Aspen Surgical, B. Braun Melsungen AG, Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Hu-Friedy Mfg. Co., LLC, SteriLance Medical (Suzhou) Inc., Merit Medical Systems, Inc., Shanghai Medical Corporation, Swann-Morton Limited, and other key market players.

Merit Medical Systems (NASDAQ:MMSI) and Teleflex (NYSE:TFX) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, analyst recommendations and earnings. Risk and Volatility Merit Medical Systems has a beta of 1.13, suggesting that its share price []

Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) have been assigned a consensus recommendation of Buy from the seven ratings firms that are currently covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 1 year price []

Brokerages expect Merit Medical Systems, Inc. (NASDAQ:MMSI) to announce earnings of $0.50 per share for the current quarter, Zacks Investment Research reports. Four analysts have made estimates for Merit Medical Systems earnings. The highest EPS estimate is $0.54 and the lowest is $0.44. Merit Medical Systems reported earnings per share of $0.54 in the same []

Merit Medical Systems (NASDAQ:MMSI) issued an update on its FY 2021 earnings guidance on Tuesday morning. The company provided EPS guidance of $2.070-$2.220 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.170. The company issued revenue guidance of $1.06 billion-$1.07 billion, compared to the consensus revenue estimate of $1.07 billion. NASDAQ []

Stents can be used for similar reasons in the trachea, especially to maintain lumen patency to prevent death. Stenting in the tracheobronchial tree is usually used as a last resort for severe conditions such as recurrent carcinoma and severe tracheal

Parametric Portfolio Associates LLC cut its position in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 0.8% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 194,810 shares of the medical instruments suppliers stock after selling 1,649 shares during the period. Parametric Portfolio Associates LLC owned approximately 0.35% []

The Embolization Particle Market Report 2021-2027 provides global market size, regional and national level market size, market segment growth, market share, competitive landscape, sales analysis, influence of domestic and global market participants, and value chain Detailed analysis of optimization, trade

SOUTH JORDAN, Utah, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary medical devices used in interventional, diagnosti

SOUTH JORDAN, Utah, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it has reached an agreement in principle to settle the securities class action lawsuit against Merit and its Chief Executive Officer and Chief Financial Officer currently pending in the United States District Court for the Central District of California. The lawsuit was filed in June 2020 after Merits stock price declined following disclosures made by Merit with respect to its operating and financial performance during 2019. The settlement was reached following a voluntary mediation process.

Merit Medical Systems, Inc. (NASDAQ:MMSI) was the recipient of a large drop in short interest in the month of October. As of October 29th, there was short interest totalling 1,190,000 shares, a drop of 24.2% from the October 14th total of 1,570,000 shares. Based on an average trading volume of 254,700 shares, the short-interest ratio []

Equities analysts expect Merit Medical Systems, Inc. (NASDAQ:MMSI) to post $0.50 earnings per share (EPS) for the current fiscal quarter, Zacks reports. Four analysts have provided estimates for Merit Medical Systems earnings, with estimates ranging from $0.44 to $0.54. Merit Medical Systems posted earnings per share of $0.54 during the same quarter last year, which []

Equities research analysts expect that Merit Medical Systems, Inc. (NASDAQ:MMSI) will post sales of $269.94 million for the current quarter, according to Zacks Investment Research. Four analysts have provided estimates for Merit Medical Systems earnings. The highest sales estimate is $271.93 million and the lowest is $267.23 million. Merit Medical Systems reported sales of $258.00 []